Allspring Global Investments’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.1M | Sell |
134,066
-7,535
| -5% | -$625K | 0.02% | 677 |
|
|
2025
Q1 | $11.5M | Sell |
141,601
-12,717
| -8% | -$1.03M | 0.02% | 670 |
|
|
2024
Q4 | $13.9M | Sell |
154,318
-9,142
| -6% | -$823K | 0.02% | 649 |
|
|
2024
Q3 | $16.1M | Sell |
163,460
-9,365
| -5% | -$925K | 0.03% | 624 |
|
|
2024
Q2 | $16M | Sell |
172,825
-10,202
| -6% | -$946K | 0.03% | 623 |
|
|
2024
Q1 | $17.4M | Sell |
183,027
-18,785
| -9% | -$1.78M | 0.03% | 595 |
|
|
2023
Q4 | $18M | Buy |
201,812
+20,734
| +11% | +$1.85M | 0.03% | 586 |
|
|
2023
Q3 | $13.2M | Sell |
181,078
-25,177
| -12% | -$1.84M | 0.02% | 667 |
|
|
2023
Q2 | $17.2M | Buy |
206,255
+1,167
| +0.6% | +$97.1K | 0.03% | 641 |
|
|
2023
Q1 | $15.6M | Sell |
205,088
-8,430
| -4% | -$642K | 0.03% | 666 |
|
|
2022
Q4 | $17.7M | Buy |
213,518
+8,363
| +4% | +$694K | 0.03% | 615 |
|
|
2022
Q3 | $16.3M | Sell |
205,155
-4,306
| -2% | -$342K | 0.03% | 615 |
|
|
2022
Q2 | $15.6M | Buy |
209,461
+34,568
| +20% | +$2.57M | 0.03% | 661 |
|
|
2022
Q1 | $15.7M | Sell |
174,893
-3,958
| -2% | -$356K | 0.02% | 743 |
|
|
2021
Q4 | $20M | Buy |
+178,851
| New | +$20M | 0.02% | 704 |
|